GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors

By sjmartinez • September 1, 2024

Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors. JACC Heart Fail. 2024 Aug 16:S2213-1779(24)00561-4. doi: 10.1016/j.jchf.2024.07.006. Epub ahead of print. PMID: 39207323.

Tags: Cardiology/Epi, GLP-1 receptor agonists, Heart failure with preserved ejection fraction, Obesity, overweight, Publications, SGLT2is

CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on Magnetic Resonance Imaging: The MESA COPD Study

Hermann EA, Yang JX, Angelini E, Balte P, Bluemke DA, Carr J, Derlin K, Gomes AS, Habibi M, Hoffman EA, Johns C, Kawut SM, Kiely[...]

Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis

Packard RRS, deKemp RA, Knuuti J, Moody JB, Renaud JM, Saraste A, Slomka PJ. Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis. J Nucl Cardiol.[...]

Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study

Jimenez J, Ni H, Katz SD, Haas GJ, Cao J, Rubens M, Chaparro S, Saxena A, Hofmeyer M, Kransdorf E, Ewald GA, Morris AA, Owens[...]